The molecular mechanisms underlying nephrotic syndrome (NS) are unknown. In this three-way collaboration between Duke University (primary), University of Miami, and University of Michigan, we will examine the role of genetic defects in RCAN1 and other genes in the calcineurin signaling pathways in the pathogenesis of NS, identify predictors of response to calcineurin inhibitors, and new therapeutic targets for NS. We are excited to bring the drug discovery technologies of the Ali lab to bear on nephrotic syndrome with world-class experts in this area!
top of page
Recent PostsSee All
Cole got accepted into the NSF sponsored summer research experience (REU) at UM! He will be working on an AI-based model for cancer diagnosis and extraction of relevant features using biomedical data.
We recently heard that Abdiel's NIH Diversity Supplement will be funded by NIH/NINDS. This will support Abdiel's graduate work in the Ali Lab and will contribute to his training as a scientist and a f
We are excited to share that our BPN program, aimed at developing a treatment for spinal cord injury (SCI), has transitioned form the UG3 (exploratory) phase to the UH3 (development) phase. With only
bottom of page